Emerging monitoring technologies in kidney transplantation
- 1 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 36 (10), 3077-3087
- https://doi.org/10.1007/s00467-021-04929-9
Abstract
Non-invasive technologies to monitor kidney allograft health utilizing high-throughput assays of blood and urine specimens are emerging out of the research realm and slowly becoming part of everyday clinical practice. HLA epitope analysis and eplet mismatch score determination promise a more refined approach to the pre-transplant recipient–donor HLA matching that may lead to reduced rejection risk. High-resolution HLA typing and multiplex single antigen bead assays are identifying potential new offending HLA antibody subtypes. There is increasing recognition of the deleterious role non-HLA antibodies play in post-transplant outcomes. Donor-derived cell-free DNA detected by next-generation sequencing is a promising biomarker for kidney transplant rejection. Multi-omics techniques are shedding light on discrete genomic, transcriptomic, proteomic, and metabolomic signatures that correlate with and predict allograft outcomes. Over the next decade, a comprehensive approach to optimize kidney matching and monitor transplant recipients for acute and chronic graft dysfunction will likely involve a combination of those emerging technologies summarized in this review.Keywords
This publication has 80 references indexed in Scilit:
- Immunologic monitoring in kidney transplant recipientsKidney Research and Clinical Practice, 2013
- Pretransplant anti-HLA-Cw and anti-HLA-DP antibodies in sensitized patientsHuman Immunology, 2012
- Understanding crossmatch testing in organ transplantation: A case‐based guide for the general nephrologistNephrology, 2011
- Cell-Free DNA as a Noninvasive Acute Rejection Marker in Renal TransplantationClinical Chemistry, 2009
- Characterization of circulating DNA in healthy human plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 2008
- Antibodies against MICA Antigens and Kidney-Transplant RejectionThe New England Journal of Medicine, 2007
- Antibody-mediated organ-allograft rejectionNature Reviews Immunology, 2005
- Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft RejectionThe New England Journal of Medicine, 2005
- About the possible origin and mechanism of circulating DNA: Apoptosis and active DNA releaseClinica Chimica Acta; International Journal of Clinical Chemistry, 2001
- Noninvasive Diagnosis of Renal-Allograft Rejection by Measurement of Messenger RNA for Perforin and Granzyme B in UrineThe New England Journal of Medicine, 2001